MNTA: At this point, it is difficult to know all of the settings in which the drug might be positioned. However, I agree with you. Also, they (imo) undervalued the partnership terms for M118. We will get a M118 PR this week. I don't know if there is an abstract.
"If we don't succeed, we run the risk of failure." -Dan Quayle